Gilead Sciences Announces 8 Percent Increase In First Quarter 2020 Dividend
February 04 2020 - 4:02PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the
company’s Board of Directors has declared an increase of 8% in the
company’s quarterly cash dividend, beginning in the first quarter
of 2020. The increase will result in a quarterly dividend of $0.68
per share of common stock. The dividend is payable on March 30,
2020, to stockholders of record at the close of business on March
13, 2020. Future dividends will be subject to Board approval.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical
company that discovers, develops and commercializes innovative
medicines in areas of unmet medical need. The company strives to
transform and simplify care for people with life-threatening
illnesses around the world. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200204005923/en/
Investors Andrew Dickinson
(650) 524-0862
Douglas Maffei, Ph.D. (650) 522-2739
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024